A recent study and editorial published in the New England Journal of Medicine indicated that x-ray mammography screening may "save" only 1 person for every 2,500 screened.

Among the 2,500 screened at least 1,000 will have a false alarm, 500 would undergo an unnecessary biopsy, and 5 or more would become treated for abnormal finds that would never become fatal, i.e. their lives will be shortened due to medication/surgical/stress-induced adverse effects.

Given these findings X-ray mammography may be far more effective at generating increased numbers of breast cancer diagnoses than in "preventing" malignancy and mortality associated with the disease. To the contrary, a growing body of clinical evidence indicates that the "low energy" x-rays used in breast screenings are up to 500% more carcinogenic than previously assumed and upon which current radiation risk models that favor mass breast screenings with ionizing diagnostic technologies find justification.

The success of this highly popularized model of "prevention," which prevents nothing, is explained when we look deeper into who is behind AstraZeneca, the founding sponsor of National Breast Cancer Awareness Month.

Internet site reference: http://articles.mercola.com/sites/articles/archive/2011/10/21/seeing-red-over-pink-the-dark-side-of-breast-cancer-awareness-month.aspx?e_cid=20111021_DNL_art_1